These findings are further corroborated by our experiments involving AAV-mediated Mst1 expression in a mouse model of Parkinson’s disease, in which Mst1 expression ameliorated motor deficits and improved the survival of dopaminergic neurons. Here, MST1 is linked to Parkinson disease.